Asbestosis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials
• Forums

Integration of the PD-L1 Inhibitor Atezolizumab and WT1/DC Vaccination Into Platinum/Pemetrexed-based First-line Treatment for Epithelioid Malignant Pleural Mesothelioma
Condition:   Malignant Pleural Mesothelioma Interventions:   Biological: Dendritic cell vaccination;   Drug: Atezolizumab;   Drug: Platinum/pemetrexed based chemotherapy Sponsors:   University Hospital, Antwerp;   Algemeen Ziekenhuis Maria Middelares;   Vitaz;   Kom Op Tegen Kanker;   Roche Pharma AG Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 13, 2023 Category: Research Source Type: clinical trials

MAGIC AKI: Magnesium for the Prevention of HIOC-Associated AKI
Condition:   Mesothelioma Interventions:   Drug: Magnesium sulfate;   Drug: Normal Saline Sponsors:   Brigham and Women's Hospital;   National Institutes of Health (NIH);   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 16, 2023 Category: Research Source Type: clinical trials